Waverley Pharma Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CAD 0.303907 million compared to CAD 0.359963 million a year ago. Net loss was CAD 0.31099 million compared to CAD 0.17387 million a year ago. Basic loss per share from continuing operations was CAD 0.01.